Allergan Pharmaceuticals International Limited trademarks
Allergan Pharmaceuticals International Limited owns 309 unique trademarks in 6 jurisdictions, combined from 10 owner names in the registers. 87 of them are active.
- Unique trademarks321 register records
- 309
- Active28% of unique marks
- 87
- Jurisdictions
- 6
- Owner names grouped
- 10
Where Allergan Pharmaceuticals International Limited protects its brands
Each mark counts once here: an international registration is grouped with its country designations, not counted once per country. That gives the 309 unique marks above, from 321 register records.
By classA mark can cover several classes
- Class 5Pharmaceuticals26686%
- Class 44Medical, Beauty, and Agricultural289%
- Class 41Education and Entertainment196%
- Class 35Advertising and Business155%
- Class 42Computer and Scientific Services103%
- Class 9Computers and Scientific Devices83%
- Class 16Paper Goods and Printed Matter83%
- Class 10Medical Apparatus72%
+5 more
Filings per year
New trademarks Allergan Pharmaceuticals International Limited has filed each year, counting each mark once.
- Peak year · 45 filed
- 2012
- 2022 to 2026 · filed
- 44
- First filing
- 1937
Filings by year: 1937: 1, 1952: 1, 1972: 2, 1974: 1, 1975: 1, 1977: 3, 1978: 2, 1979: 1, 1982: 1, 1986: 1, 1987: 1, 1988: 1, 1990: 2, 1993: 2, 1995: 2, 1996: 5, 1998: 5, 1999: 7, 2000: 2, 2001: 5, 2002: 2, 2003: 6, 2004: 6, 2005: 9, 2006: 8, 2007: 4, 2008: 6, 2009: 16, 2010: 11, 2011: 3, 2012: 45, 2013: 17, 2014: 8, 2015: 7, 2016: 20, 2017: 16, 2018: 23, 2019: 6, 2020: 6, 2022: 10, 2023: 10, 2024: 5, 2025: 9, 2026: 10.
Oppositions, cancellations and ownership changes
Proceedings Allergan Pharmaceuticals International Limited has been part of, and the assignments recorded against its marks.
Disputes & oppositions
- Proceedings
- 15
- As challenger
- 1
- As defendant
- 14
By proceeding type
- Opposition12
- Cancellation2
- Appeal1
Outcomes
- Other12
- Withdrawn2
- Pending1
Assignments & security interests
- Transactions
- 14
- Marks acquired
- 10
- Marks divested
- 4
- Marks with liens
- 0
- Unreleased security interests
- 0
- Assignment11
- Merger1
- Correction1
- Name change1
Recorded from 2015-12-10 to 2025-02-19.
Latest filings
The most recent applications across Allergan Pharmaceuticals International Limited's owner names.
Browse all 321 register records| Mark | Status | Office | Classes | Filed |
|---|---|---|---|---|
| HARMONYCA | pending opposition | EUIPO | 5 | 2026-08-24 |
| HARMONYCA | pending opposition | USPTO | 5 | 2026-08-24 |
| DART DUAL ACTION REGENERATION TECHNOLOGY | examining | USPTO | 5, 42 | 2026-07-17 |
| DART DUAL ACTION REJUVENATING TECHNOLOGY | examining | USPTO | 5, 42 | 2026-05-13 |
| [Design Mark] | pending opposition | USPTO | 5, 42 | 2026-02-27 |
| DART Logo | filed | CIPO | 5, 42 | 2026-02-25 |
About Allergan Pharmaceuticals International Limited's trademarks
How many trademarks does Allergan Pharmaceuticals International Limited own?
Allergan Pharmaceuticals International Limited owns 309 unique trademarks across the registers Signa tracks, filed as 321 register records.
How many of Allergan Pharmaceuticals International Limited's trademarks are registered?
71 of Allergan Pharmaceuticals International Limited's unique marks are registered.
Where does Allergan Pharmaceuticals International Limited file the most trademarks?
Allergan Pharmaceuticals International Limited holds the most marks at the USPTO, with 241 unique marks.
Get this data via the API
Every number on this page comes from the Signa API. Pull Allergan Pharmaceuticals International Limited's portfolio into your own product with one request.
GET/v1/entities/{id}/analyticsPortfolio, disputes and ownership changes
GET/v1/entities/{id}Company record, ticker, LEI and owner names
GET/v1/entities/{id}/trademarksEvery trademark in the portfolio
ID=ent_019eb6f6-367b-76c9-bac1-b8a3940da1c9
curl https://api.signa.so/v1/entities/$ID/analytics \
-H "Authorization: Bearer $SIGNA_API_KEY"{
"object": "analytics_report",
"subject": {
"id": "ent_019eb6f6-367b-76c9-bac1-b8a3940da1c9",
"object": "entity",
"name": "Allergan Pharmaceuticals International Limited"
},
"portfolio": {
"mark_count": 309,
"active_count": 87,
"jurisdiction_spread": {
"US": 241,
"CA": 34,
"EU": 20
}
}
}